Skip to main content
fghjkjhb

Evidence gap analysis

Strategic analysis of the sufficiency of evidence to obtain reimbursement and HTA approval in Europe and recommendations about evidence generation

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

The decision regarding new CCAM procedure codes published in France

On April 8, 2025, the decision of the National Union of Health Insurance Funds on the update of the Common Classification of Medical Procedures (CCAM) was published in the Official Journal of the French Republic. The CCAM Classification serves as a reimbursement nomenclature of medical procedures. The CCAM codes are used for DRG grouping (hospital payment mechanism) and have nationally established CCAM fees, which apply to services provided by non-salaried physicians in private for-profit hospitals and outpatient specialist care.

Changes include the introduction of five new procedure codes, provisional registration of four procedure codes, modification of an existing code, and modification of an increase (“majoration”) related to public holidays.

Newly introduced procedure codes concern cardiovascular and peripheral vascular procedures, interventional radiology, ENT, and others. Some examples of newly introduced codes are provided below:

  • DELA169 “Subcutaneous implantation of a cardiac defibrillator with retrosternal lead placement, via subxiphoid approach” with a CCAM fee of €480.35;
  • EJSF400 “Radiofrequency ablation of the small saphenous vein via percutaneous endovenous approach with ultrasound guidance” with a CCAM fee of €168.68.

Four procedure codes for targeted prostate biopsies were provisionally registered in the CCAM Classification for three years.

Additionally, the indications for procedure code HLQM702 “Transcutaneous ultrasound of the liver with intravenous injection of the contrast agent” were extended.

The decision takes effect July 1, 2025. An updated version of the CCAM Nomenclature has not been published yet.

See the details in French here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.